Thyroid diseases in elderly

Minerva Endocrinologica

Volumn 36, Issue 3, 2011, Pages 211-231

  Faggiano, A ^a   Del Prete, M ^b   Marciello, F ^b   Marotta, V ^b   Ramundo, V ^b   Colao, A ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Aged; Hyperthyroidism; Hypothyroidism; Thyroid neoplasms; Thyroid nodule

Indexed keywords

AMIODARONE; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTITHYROID AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN DERIVATIVE; FLUOROURACIL; GLUCOCORTICOID; IODINE DERIVATIVE; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM CARBONATE; METFORMIN; MITOTANE; PHENOBARBITAL; PROTON PUMP INHIBITOR; RADIOACTIVE IODINE; RIFAMPICIN; SOMATOSTATIN DERIVATIVE; THYROTROPIN; THYROXINE;

AGED; AUTOIMMUNE THYROIDITIS; COMORBIDITY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LABORATORY TEST; MEDICAL HISTORY; PHYSICAL EXAMINATION; PREVALENCE; RADIATION SICKNESS; REVIEW; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION; THYROID NODULE; THYROID SURGERY; THYROIDECTOMY; THYROTOXICOSIS; TOXIC GOITER;

AGED; AGED, 80 AND OVER; AGING; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; ITALY; PREVALENCE; RISK FACTORS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID NEOPLASMS; THYROID NODULE;

EID: 84255183264     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (139)

1. Mariotti S, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocr Rev 1995;16:686-715.
2. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998;83:765-9. (Pubitemid 28496981)
3. Diez JJ. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology 2003;49:316-23. (Pubitemid 37034368)
4. Tsang W, Houlden RL. Amiodarone-induced thyrotoxicosis: a review. Can J Cardiol 2009;25:421-4.
5. Trivalle C, Doucet J, Chassagne P, Landrin I, Kadri N, Menard JF et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996;44:50-3. (Pubitemid 26017766)
6. Biondi B, Kahaly GJ. Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 2010;6:431-43.
7. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008;29:76-131. (Pubitemid 351252748)
8. Kim JM, Stewart R, Kim SY, Bae KY, Yang SJ, Kim SW et al. Thyroid stimulating hormone, cognitive impairment and depression in an older korean population. Psychiatry Investig 2010;7:264-9.
9. Turner MR, Camacho X, Fischer HD, Austin PC, Anderson GM, Rochon PA et al. Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ 2010;342:d2238.
10. Vestergaard P, Rejnmark L, Weeke J, Mosekilde L. Fracture risk in patients treated for hyperthyroidism. Thyroid 2000;10:341-8. (Pubitemid 30256864)
11. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006;295:1033-41.
12. Kahaly GJ, Nieswandt J, Mohr-Kahaly S. Cardiac risks of hyperthyroidism in the elderly. Thyroid 1998;8:1165-9. (Pubitemid 29042551)
13. Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Koukkou E et al. Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J Clin Endocrinol Metab 2006,91:1112-8. (Pubitemid 43357789)
14. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-38. (Pubitemid 38082818)
15. Mitrou P, Raptis SA, Dimitriadis G. Thyroid disease in older people. Maturitas 2011;70:5-9.
16. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM et al. 2002 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2010;8:457-69.
17. Raffaelli M, Bellantone R, Princi P, De Crea C, Rossi ED, Fadda G et al. Surgical treatment of thyroid diseases in elderly patients. Am J Surg 2010;200:467-72.
18. Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 2010;95:2529-35.
19. Papini E, Guglielmi R, Bizzarri G, Pacella CM. Ultrasound-guided laser thermal ablation for treatment of benign thyroid nodules. Endocr Pract 2004;10:276-83.
20. Spiezia S, Garberoglio R, Milone F, Ramundo V, Caiazzo C, Assanti AP et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 2009;19:219-25.
21. Deandrea M, Limone P, Basso E, Mormile A, Ragazzoni F, Gamarra E et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 2008;34:784-91. (Pubitemid 351621898)
22. Zingnllo M, Torlontano M, Ghiggi MR, Frusciante V, Varraso A, Liuzzi A et al. Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study. Thyroid 2000;10:985-9. (Pubitemid 32106683)
23. Papini E, Panunzi C, Pacella CM, Bizzarri G, Fabbrini R, Petrucci L et al. Percutaneous ultrasound-guided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules? J Clin Endocrinol Metab 1993;76:411-6. (Pubitemid 23073065)
24. Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009;94:1251-4.
25. Simonsick EM, Newman AB, Ferrucci L, Satterfield S, Harris TB, Rodondi N et al. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med 2009;169:2011-7.
26. Gopinath B, Wang JJ, Kifley A, Wall JR, Eastman CJ, Leeder SR et al. Five-year incidence and progression of thyroid dysfunction in an older population. Intern Med J 2010;40:642-9.
27. Mooradian AD. Subclinical hypothyroidism in the elderly: to treat or not to treat? Am J Ther 2010. [Epub ahead of print].
28. Mariotti S, Chiovato L, Franceschi C, Pinchera A. Thyroid autoimmunity and aging. Exp Gerontol 1998;33.535-41.
29. Chiovato L, Mariotti S, Pinchera A. Thyroid diseases in the elderly. Baillieres Clin Endocrinol Metab 1997;11:251-70. (Pubitemid 27485027)
30. Haentjens P, Van Meerhaeghe A, Poppe K, Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol 2008;159:329-41.
31. Ohzeki T, Hanaki K, Motozumi H, Ohtahara H, Ishitani N, Urashima H et al. 1993 Efficacy of bromocriptine administration for selective pituitary resistance to thyroid hormone. Horm Res 2010;39:229-34.
32. Samuels MH, Henry P, Ridgway EC. Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab 1992;74:217-22.
33. Kok P, Roelfsema F, Frolich M, van Pelt J, Meinders AE, Pijl H. Bromocriptine reduces augmented thyrotropin secretion in obese premenopausal women. J Clin Endocrinol Metab 2009;94:1176-81.
34. Lewis BM, Dieguez C, Lewis MD, Scanlon MF. Dopamine stimulates release of thyrotrophin-releasing hormone from perfused intact rat hypothalamus via hypothalamic D2-receptors. J Endocrinol 1987;115:419-24. (Pubitemid 18003079)
35. van't Verlaat JW, Croughs RJ, Hendriks MJ, Bosma NJ, Nortier JW, Thijssen JH. Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study. Acta Endocrinol (Copenh) 1986;112:487-93. (Pubitemid 16040634)
36. Brabant A, Brabant G, Schuermeyer T, Ranft U, Schmidt FW, Hesch RD et al. The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol (Copenh) 1989;121:95-100. (Pubitemid 19167537)
37. Samuels MH. Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study. J Clin Endocrinol Metab 2000;85:1388-93. (Pubitemid 32289478)
38. Samuels MH, McDaniel PA. Thyrotropin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: a clinical research center study. J Clin Endocrinol Metab 1997;82:3700-4. (Pubitemid 27509358)
39. Wilber JF, Utiger RD. The effect of glucocorticoids on thyrotropin secretion. J Clin Invest 1969;48:2096-103.
40. Nicoloff JT, Fisher DA, Appleman MD Jr. The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest 1970;49:1922-9.
41. John CD, Christian HC, Morris JF, Flower RJ, Solito E, Buckingham JC. Kinase-dependent regulation of the secretion of thyrotrophin and luteinizing hormone by glucocorticoids and annexin 1 peptides. J Neuroendocrinol 2003;15:946-57. (Pubitemid 37193011)
42. Cintra A, Fuxe K, Wikstrom AC, Visser T, Gustafsson JA. Evidence for thyrotropin-releasing hormone and glucocorticoid receptor-immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat. Brain Res 1990;506:139-44. (Pubitemid 20020086)
43. Alkemade A, Unmehopa UA, Wiersinga WM, Swaab DF, Fliers E. Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab 2005;90:323-7. (Pubitemid 40116675)
44. Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocr Rev 1995;16:427-42.
45. Lamberts SW, Zuyderwijk J, den Holder F, van Koetsveld P, Hofland L. Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells. Neuroendocrinology 1989;50:44-50. (Pubitemid 19152163)
46. Lightman SL, Fox P, Dunne MJ. The effect of SMS 201-995, a long-acting somatostatin analogue, on anterior pituitary function in healthy male volunteers. Scand J Gastroenterol Suppl 1986;119:84-95. (Pubitemid 16057847)
47. Kirkegaard C, Norgaard K, Snorgaard O, Bek T, Larsen M, Lund-Andersen H. Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus. Acta Endocrinol (Copenh) 1990;122:766-72. (Pubitemid 20220425)
48. Colao A, Merola B, Ferone D, Marzullo P, Cerbone G, Longobardi S et al. Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas. Eur J Endocrinol 1995;133:189-94.
49. Roelfsema F, Frolich M. Pulsatile thyrotropin release and thyroid function in acromegalics before and during subcutaneous octreotide infusion. J Clin Endocrinol Metab 1991;72:77-82. (Pubitemid 21921659)
50. Miller J, Carney P. Central hypothyroidism with oxcarbazepine therapy. Pediatr Neurol 2006;34:242-4.
51. Vigersky RA, Filmore-Nassar A, Glass AR. Thyrotropin suppression by metformin. J Clin Endocrinol Metab 2006;91:225-7. (Pubitemid 43069142)
52. Cappelli C, Rotondi M, Pirola I, Agosti B, Gandossi E, Valentini V et al. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care 2009;32:1589-90.
53. Isidro ML, Penin MA, Nemina R, Cordido F. Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine 2007;32:79-82. (Pubitemid 350242550)
54. Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab 2009;23:723-33.
55. Deniker P, Eyquem A, Bernheim R, Loo H, Delanie P. Thyroid autoantibody levels during lithium therapy. Neuropsychobiology 1978;4:270-5. (Pubitemid 8313446)
56. Braverman LE. Iodine induced thyroid disease. Acta Med Austriaca 1990;17(Suppl 1):29-33. (Pubitemid 20237787)
57. Philippou G, Koutras DA, Piperingos G, Souvatzoglou A, Moulopoulos SD. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin Endocrinol (Oxf) 1992;36:573-8.
58. Dowsett M, Mehta A, Cantwell BM, Harris AL. Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. Eur J Cancer 1991;27:846-9.
59. Gupta A, Eggo MC, Uetrecht JP, Cribb AE, Daneman D, Rieder MJ et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther 1992;51:56-67.
60. Hays MT. Thyroid hormone and the gut. Endocr Res 1988;14:203-24.
61. Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006;354:1787-95.
62. Wenzel KW, Kirschsieper HE. Aspects of the absorption of oral L-thyroxine in normal man. Metabolism 1977;26:1-8. (Pubitemid 8027634)
63. Shakir KM, Michaels RD, Hays JH, Potter BB. The use of bile acid sequestrants to lower serum thyroid hormones in iatrogenic hyperthyroidism. Ann Intern Med 1993;118:112-3. (Pubitemid 23013627)
64. Havrankova J, Lahaie R. Levothyroxine binding by sucralfate. Ann Intern Med 1992;117:445-6.
65. Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992;117:1010-3.
66. Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid 2001;11:967-71. (Pubitemid 33020185)
67. Bartalena L, Robbins J. Variations in thyroid hormone transport proteins and their clinical implications. Thyroid 1992;2:237-45.
68. Kuhl H, Jung-Hoffmann C, Weber J, Boehm BO. The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters. Contraception 1993;47:55-68. (Pubitemid 23041432)
69. Steingold KA, Matt DW, DeZiegler D, Sealey JE, Fratkin M, Reznikov S. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. J Clin Endocrinol Metab 1991;73:275-80. (Pubitemid 21921869)
70. Mamby CC, Love RR, Lee KE. Thyroid function test changes with adjuvant tamoxifen therapy in postmenopausal women with breast cancer. J Clin Oncol 1995;13:854-57.
71. Beex L, Ross A, Smals A, Kloppenborg P. 5-fluorouracil-induced increase of total serum thyroxine and triiodothyronine. Cancer Treat Rep 1977;61:1291-5. (Pubitemid 8204097)
72. van Seters AP, Moolenaar AJ. Mitotane increases the blood levels of hormone-binding proteins. Acta Endocrinol (Copenh) 1991;124:526-33.
73. Deyssig R, Weissel M. Ingestion of androgenic-anabolic steroids induces mild thyroidal impairment in male body builders. J Clin Endocrinol Metab 1993;76:1069-71. (Pubitemid 23110864)
74. Arafah BM. Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer. Ann Intern Med 1994;121:247-51.
75. Cashin-Hemphill L, Spencer CA, Nicoloff JT, Blankenhorn DH, Nessim SA, Chin HP et al. Alterations in serum thyroid hormonal indices with colestipolniacin therapy. Ann Intern Med 1987;107:324-9.
76. Witztum JL, Jacobs LS, Schonfeld G. Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride. J Clin Endocrinol Metab 1978;46:838-40. (Pubitemid 8345879)
77. Newnham HH, Hamblin PS, Long F, Lim CF, Topliss DJ, Stockigt JR. Effect of oral frusemide on diagnostic indices of thyroid function. Clin Endocrinol (Oxf) 1987;26:423-31. (Pubitemid 17045709)
78. McConnell RJ. Abnormal thyroid function test results in patients taking salsalate. JAMA 1992;267:1242-3.
79. Herschman JM, Jones CM, Bailey AL. Reciprocal changes in serum thyrotropin and free thyroxine produced by heparin. J Clin Endocrinol Metab 1972;34:574-9.
80. Mendel CM, Frost PH, Kunitake ST, Cavalieri RR. Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. J Clin Endocrinol Metab 1987;65:1259-64. (Pubitemid 18026868)
81. Curran PG, DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 1991;12:135-50.
82. Liewendahl K, Tikanoja S, Helenius T, Majuri H. Free thyroxin and free triiodothyronine as measured by equilibrium dialysis and analog radioimmunoassay in serum of patients taking phenytoin and carbamazepine. Clin Chem 1985;31:1993-6. (Pubitemid 16052434)
83. Cooper DS, Daniels GH, Ladenson PW, Ridgway EC. Hyperthyroxinemia in patients treated with high-dose propranolol. Am J Med 1982;73.867-71.
84. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007;298:1312-22. (Pubitemid 47449439)
85. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev 2001;22:240-54. (Pubitemid 32458161)
86. Sogol PB, Hershman JM, Reed AW, Dillmann WH. The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5′-monodeiodination in rats. Endocrinology 1983;113:1464-9. (Pubitemid 13009161)
87. Krenning EP, Docter R, Bernard B, Visser T, Hennemann G. Decreased transport of thyroxine (T4), 3,3′,5-triiodothyronine (T3) and 3,3′,5′-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs. FEBS Lett 1982;140:229-33. (Pubitemid 12083934)
88. Melmed S, Nademanee K, Reed AW, Hendrickson JA, Singh BN, Hershman JM. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab 1981;53:997-1001. (Pubitemid 13229581)
89. Franklyn JA, Davis JR, Gammage MD, Littler WA, Ramsden DB, Sheppard MC. Amiodarone and thyroid hormone action. Clin Endocrinol (OxO 1985;22:257-64.
90. Safran M, Fang SL, Bambini G, Pinchera A, Martino E, Braverman LE. Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat. Am J Med Sci 1986;292:136-41. (Pubitemid 17043103)
91. Monteiro E, Galvao-teles A, Santos ML, Mourao L, Correia MJ, Lopo Tuna J et al. Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. Br Med J (Clin Res Ed) 1986;292:227-8. (Pubitemid 16161980)
92. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 2007;36:707-35. (Pubitemid 47135591)
93. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764-71.
94. Gupta KL. Neoplasm of the thyroid gland. Clin Geriatr Med 1995;11:271-90.
95. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-9. (Pubitemid 23053833)
96. Pinchera A, Aghini-Lombardi F, Antonangeli L, Vitti P. [Multinodular goiter. Epidemiology and prevention]. Ann Ital Chir 1996,67:317-25.
97. Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME et al. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006;12:63-102.
98. Gough J, Scott-Coombes D, Fausto Palazzo F. Thyroid incidentaloma: an evidence-based assessment of management strategy. World J Surg 2008;32:1264-8.
99. Smallridge RC. Metabolic and anatomic thyroid emergencies: a review. Crit Care Med 1992;20:276-91.
100. Eng CY, Quraishi MS, Bradley PJ. Management of thyroid nodules in adult patients. Head Neck Oncol 2010;2:11.
101. Solbiati L, Osti V, Cova L, Tonolini M. Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol 2001;11:2411-24. (Pubitemid 33114892)
102. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226-31. (Pubitemid 27061578)
103. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993;118:282-9. (Pubitemid 23046388)
104. Jarlov AE, Nygaard B, Hegedus L, Hartling SG, Hansen JM. Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. Thyroid 1998;8:393-8. (Pubitemid 28252420)
105. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 1987;317:70-5. (Pubitemid 17093734)
106. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001;358:861-5. (Pubitemid 32900566)
107. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 1996;81:4278-89. (Pubitemid 26412030)
108. Mehta V, Savino JA. Surgical management of the patient with a thyroid disorder. Clin Geriatr Med 1995;11:291-309.
109. Sakorafas GH, Peros G. Thyroid nodule: a potentially malignant lesion; optimal management from a surgical perspective. Cancer Treat Rev 2006;32:191-202.
110. Meier DA, Brill DR, Becker DV, Clarke SE, Silberstein EB, Royal HD et al. Procedure guideline for therapy of thyroid disease with (131)iodine. J Nucl Med 2002;43:856-61. (Pubitemid 34663310)
111. Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H, Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab 2007;92:2190-6. (Pubitemid 46997120)
112. Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A. Outcome of radioiodine-13, therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study. Clin Endocrinol (Oxf) 2005;62:331-5. (Pubitemid 40380414)
113. Guglielmi R, Pacella CM, Bianchini A, Bizzarri G, Rinaldi R, Graziano FM et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 2004;14:125-31. (Pubitemid 38375499)
114. Spiezia S, Vitale G, Di Somma C, Pio Assanti A, Ciccarelli A, Lombardi G et al. Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid 2003;13:941-7. (Pubitemid 37351877)
115. Spiezia S, Garberoglio R, Di Somma C, Deandrea M, Basso E, Limone PP et al. Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. J Am Geriatr Soc 2007;55:1478-9. (Pubitemid 47329245)
116. Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008;22:901-11.
117. Bartolotta TV, Midiri M, Runza G, Galia M, Taibbi A, Damiani L et al. Incidentally discovered thyroid nodules: incidence, and greyscale and colour Doppler pattern in an adult population screened by real-time compound spatial sonography. Radiol Med 2006;111:989-98. (Pubitemid 44627698)
118. Biliotti GC, Martini F, Vezzosi V, Seghi P, Tozzi F, Castagnoli A et al. Specific features of differentiated thyroid carcinoma in patients over 70 years of age. J Surg Oncol 2006;93:194-8. (Pubitemid 43381991)
119. Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 1977;56:171-96. (Pubitemid 8111452)
120. Toniato A, Bernardi C, Piotto A, Rubello D, Pelizzo MR. Features of papillary thyroid carcinoma in patients older than 75 years. Updates Surg 2010;63:115-8.
121. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract 2010;16(Suppl 1):1-43.
122. Rukhman N, Silverberg A. Thyroid cancer in older men. Aging Male 2011;14:91-8.
123. Chiacchio S, Lorenzoni A, Boni G, Rubello D, Elisei R, Mariani G. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol 2008;33:341-57.
124. Jacob P, Kenigsberg Y, Zvonova I, Goulko G, Buglova E, Heidenreich WF et al. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br J Cancer 1999;80:1461-9. (Pubitemid 29308619)
125. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 1999;84:4232-8. (Pubitemid 30644223)
126. Nikiforov YE. Molecular analysis of thyroid tumors. Mod Pathol 2011;24(Suppl 2):S34-43.
127. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005;90:6373-9. (Pubitemid 41759286)
128. Asai N, Jijiwa M, Enomoto A, Kawai K, Maeda K, Ichiahara M et al. RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease. Pathol Int 2006;56:164-72.
129. Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 2007;31:2085-91. (Pubitemid 47620236)
130. Crile G Jr, Pontius KI, Hawk WA. Factors influencing the survival of patients with follicular carcinoma of the thyroid gland. Surg Gynecol Obstet 1985;160:409-13. (Pubitemid 15057832)
131. Coburn MC, Wanebo HJ. Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg 1995;170:471-5.
132. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:598-605. (Pubitemid 126618447)
133. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000;88:1139-48. (Pubitemid 30127676)
134. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
135. Pelizzo MR, Merante Boschin I, Toniato A, Pagetta C, Casal Ide E, Mian C et al. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma. Minerva Endocrinol 2008;33:359-79.
136. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375-81. (Pubitemid 47312122)
137. Park HS, Roman SA, Sosa JA. Treatment patterns of aging Americans with differentiated thyroid cancer. Cancer 2010;116:20-30.
138. Del Rio P, Sommaruga L, Bezer L, Arcuri MF, Cataldo S, Robuschi G et al. Thyroidectomy for differentiated carcinoma in older patients on a short stay basis. Acta Biomed 2009;80:65-8.
139. Sherman SI, Angelos P, Ball DW, Byrd D, Clark OH, Daniels GH et al. Thyroid carcinoma. J Natl Compr Canc Netw 2007;5:568-621. (Pubitemid 47057050)